Skip to content

Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk

New Physiopathogenics Mechanisms Susceptible of Pharmacological Developments (Insulin Resistance and Atherosclerosis)

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00520962
Enrollment
1997
Registered
2007-08-27
Start date
1997-06-30
Completion date
2006-05-31
Last updated
2007-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2

Keywords

cardiovascular disease, glucose intolerance, type 2 diabetes, endothelial dysfunction, inflammation, Age> 30 years, male and female, Fasting glucose below 126 mg/dl

Brief summary

The study aims to evaluate IFG, IGT or unknown type 2 diabetes mellitus in new classes at high risk to develop alterations of glucose metabolism and definition of new pathogenic mechanisms of insulin resistance and atherosclerosis. The following classes of subjects at high risk will be considered:First degree relatives of patients with type 2 diabetes mellitus, patients with cardiovascular disease and stroke, patients with heart valve disease. age will be \> 30 years, both gender.

Detailed description

The primary outcome of the study is evaluation of glucose tolerance, insulin sensitivity and insulin secretion before and 2 hours post-glucose load Secondary outcomes are evaluation of endothelial function, of natriuretic peptides and free fatty acids, and inflammation before and 2 hours post-glucose load. New candidate genes will be also evaluated.

Interventions

None listed

Sponsors

IRCCS San Raffaele
Lead SponsorOTHER

Study design

Observational model
DEFINED_POPULATION
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
30 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Fasting glucose levels \<126 mg/dl * Age \>30 years * Both male and female

Exclusion criteria

* Type 1 diabetes * Known type 2 diabetes mellitus * Pregnancy * Impaired kidney and liver function * Previous history of malignancies

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026